AU Stock MarketDetailed Quotes

IMUOE Imugene Ltd

Watchlist
  • 0.005
  • -0.001-16.67%
20min DelayMarket Closed Apr 30 15:21 AET
37.34MMarket Cap0.00P/E (Static)

About Imugene Ltd Company

Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.

Company Profile

SymbolIMUOE
Company NameImugene Ltd
Founded1986
MarketASX
Employees3
Fiscal Year Ends06-30
Address4-6 Bligh Street Suite 12.01, Level 12
CitySydney
CountryAustralia
Zip Code2000
Share RegistryAUTOMIC REGISTRY SERVICES Suite 5, Level 12, 530 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000 1300 288 664

Company Executives

  • Name
  • Position
  • Salary
  • Leslie Chong
  • Director, Chief Executive Officer and Managing Director
  • --
  • Paul E Hopper
  • Executive Chairman of the Board
  • --
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Director
  • --
  • Dr. Lesley Russell, M.R.C.P.,MB.Ch.B.
  • Independent Director
  • --
  • Dr. Jens Eckstein
  • Independent Director
  • --
  • Dr. Jakob Dupont, M.D.
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More